Table 2. Clinical outcome according to PON1-Q192R genotype.

	QQ/QR, n = 815	RR, n = 521	p-value
Primary composite end point of cardiac death, MI, and ST	18 (2.2%)	1 (0.2%)	0.002
Secondary end points
Cardiac Death	8 (1.0%)	1 (0.2%)	0.085
Myocardial infarction	11 (1.3%)	0 (0.0%)	0.008
CVA	1 (0.1%)	0 (0%)	0.422
Stent thrombosis	8 (1.0%)	0 (0.0%)	0.023
Target lesion revascularization	80 (9.8%)	47 (9.0%)	0.590
Composite of Death, MI, CVA	16 (2.3%)	4 (0.6%)	0.002
MACE	113 (13.9%)	54 (10.4%)	0.052

MI, myocardial infarction; ST, stent thrombosis; CVA; cerebrovascular accident; MACCE, major adverse cardiovascular event.

P-value by Log-rank test.